SM
BJDX icon

Sabby Management’s Bluejay Diagnostics BJDX Stock Holding History

Sabby Management’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,726
Closed -$52.9K – 26
2026
Q1 		$52.9K Buy
+28,726
New +$71K 0.12% 24
2025
Q4 		– Sell
-7,407
Closed -$45K – 36
2025
Q3 		$45K Sell
7,407
-16,601
-69% -$100K 0.05% 33
2025
Q2 		$165K Buy
+24,008
New +$196K 0.3% 26
2024
Q4 		– Sell
-1,526
Closed -$38.8K – 30
2024
Q3 		$38.8K Buy
+1,526
New +$109K 0.02% 28
2024
Q2 		– Sell
-117
Closed -$150K – 44
2024
Q1 		$150K Buy
117
+23
+24% +$31.7K 0.09% 27
2023
Q4 		$183K Buy
94
+81
+623% +$439K 0.18% 27
2023
Q3 		$91.9K Buy
+13
New +$122K 0.07% 52
2023
Q1 		– Sell
-1
Closed -$9.91K – 96
2022
Q4 		$9.91K Hold
1
– – 0.01% 103
2022
Q3 		$20K Hold
1
– – 0.03% 101
2022
Q2 		$35K Buy
+1
New +$35.5K 0.02% 108

Other funds holding BJDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Sabby Management's BJDX Position: Q2 2026 in Review

Sabby Management sold out of Bluejay Diagnostics (BJDX) in Q2 2026, closing a stake of 28,726 shares — an estimated $52.9K sold.

Sabby Management first reported a position in BJDX in Q2 2022 and held it in 10 quarters. The position peaked at $183K in Q4 2023. 8 funds tracked by Wall St. Rank hold BJDX as of Q2 2026.

  • Sabby Management reported no remaining Bluejay Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Sabby Management sold 28,726 Bluejay Diagnostics shares in Q2 2026, an estimated $52.9K.
  • Sabby Management first reported a position in Bluejay Diagnostics in Q2 2022 and held it in 10 quarters.
  • Sabby Management's Bluejay Diagnostics position peaked at $183K in Q4 2023.
  • 8 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q2 2026.

Based on Sabby Management's 13F filing for Q2 2026, filed 14 Aug 2026.